
Hematologist-Oncologist

No OPD information available
Diffuse Large B-Cell Lymphoma (DLBCL)
B-Cell Lymphoma
Classical Hodgkin Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Mononucleosis
Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Primary Mediastinal B-Cell Lymphoma (PMBCL)
Agranulocytosis
Chronic B-Cell Leukemia (CBCL)
Chronic Lymphocytic Leukemia (CLL)
Leukemia
Mediastinal Tumor
Melanoma
Small Lymphocytic Lymphoma (SLL)
T-Cell Lymphoma
Colm Keane is a male medical professional who specializes in treating various types of lymphomas and leukemias, as well as other conditions like mononucleosis, melanoma, and mediastinal tumors. He helps patients with Diffuse Large B-Cell Lymphoma (DLBCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, and many more.
Colm Keane uses special skills and treatments to help his patients fight their illnesses. He is known for his expertise in treating different types of lymphomas and leukemias, providing personalized care tailored to each patient's needs.
Patients trust Colm Keane because of his clear communication and compassionate approach. He takes the time to explain medical terms in a way that is easy to understand, making sure his patients feel informed and supported throughout their treatment journey.
Colm Keane stays updated with the latest medical knowledge and research to provide the best possible care for his patients. By staying informed about new treatments and advancements in the field, he ensures that his patients receive the most effective and cutting-edge therapies available.
In his work, Colm Keane collaborates closely with colleagues and other medical professionals to deliver comprehensive care to his patients. By working as a team, they are able to provide a multidisciplinary approach that addresses all aspects of a patient's health and well-being.
Colm Keane's dedication and expertise have made a positive impact on many patients' lives. Through his innovative treatments and compassionate care, he has helped improve the health outcomes and quality of life for numerous individuals facing challenging medical conditions.
One of Colm Keane's notable publications is the study titled "Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study," published in Blood advances. Additionally, he has been involved in clinical trials like the "RaDD Study," which explored new treatment approaches for relapsed/refractory Diffuse Large B-cell Lymphoma and Follicular Lymphoma.
In summary, Colm Keane is a dedicated and skilled medical professional who specializes in treating lymphomas, leukemias, and other related conditions. His commitment to staying updated with the latest research and his collaborative approach with colleagues have made a positive impact on his patients' lives.
Enrollment Status: Completed
Published: April 12, 2024
Intervention Type: Drug, Radiation
Study Drug: Durvalumab
Study Phase: Phase 1
